181 related articles for article (PubMed ID: 2168536)
1. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
Tanaka A; Salem M; Eckroade RJ; Fujita DJ
Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536
[TBL] [Abstract][Full Text] [Related]
2. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
3. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
4. Properties of tripartite chimeras between Src and Lck.
Kashishian A; MacAuley A; Cooper JA
Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
[TBL] [Abstract][Full Text] [Related]
5. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
[TBL] [Abstract][Full Text] [Related]
6. Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.
Bechade C; Calothy G
Oncogene; 1991 Dec; 6(12):2311-7. PubMed ID: 1662792
[TBL] [Abstract][Full Text] [Related]
7. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
8. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts.
Fincham VJ; Wyke JA; Frame MC
Oncogene; 1995 Jun; 10(11):2247-52. PubMed ID: 7784071
[TBL] [Abstract][Full Text] [Related]
9. Evidence that a phosphotyrosine-containing 120,000 Da protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src.
Lau AF
Oncogene Res; 1989; 4(3):185-94. PubMed ID: 2472591
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src.
Hamaguchi M; Yamagata S; Thant AA; Xiao H; Iwata H; Mazaki T; Hanafusa H
Oncogene; 1995 Mar; 10(6):1037-43. PubMed ID: 7535415
[TBL] [Abstract][Full Text] [Related]
11. The association of the transforming protein of Rous sarcoma virus with two cellular phosphoproteins.
Brugge JS; Darrow D; Lipsich LA; Yonemoto W
Prog Clin Biol Res; 1983; 119():135-47. PubMed ID: 6191339
[No Abstract] [Full Text] [Related]
12. Differential tyrosine-specific phosphorylation of integrin in Rous sarcoma virus transformed cells with differing transformed phenotypes.
Horvath AR; Elmore MA; Kellie S
Oncogene; 1990 Sep; 5(9):1349-57. PubMed ID: 1699197
[TBL] [Abstract][Full Text] [Related]
13. Catalytic activity and transformation potential of v-Src require arginine 385 in the substrate binding pocket.
Senften M; Schenker G; Sowadski JM; Ballmer-Hofer K
Oncogene; 1995 Jan; 10(1):199-203. PubMed ID: 7529917
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional motifs of the Rous sarcoma virus src protein.
Parsons JT; Wilkerson V; Parsons SJ
Gene Amplif Anal; 1986; 4():1-19. PubMed ID: 2851527
[TBL] [Abstract][Full Text] [Related]
15. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
Jong SM; Zong CS; Dorai T; Wang LH
J Virol; 1992 Aug; 66(8):4909-18. PubMed ID: 1321277
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of host-dependent src kinase activity by co-expression with a heterologous tyrosine kinase.
Liebl EC; England LJ; Martin GS
Virology; 1993 Jul; 195(1):265-7. PubMed ID: 8317103
[TBL] [Abstract][Full Text] [Related]
17. Rous sarcoma virus does not induce sarcoma in early chick embryos by lack of the v-src gene expression.
Ogura H; Fujiwara T; Tanaka T
Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):477-82. PubMed ID: 1336425
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
[TBL] [Abstract][Full Text] [Related]
19. Increased activity of c-Src and Csk in fibroblasts transformed by v-src oncogene.
Tuhácková Z; Vojtechová M; Hlavácek J; Ruzzene M; Sovová V; Pinna LA
Biochem Biophys Res Commun; 2002 Jan; 290(2):790-5. PubMed ID: 11785970
[TBL] [Abstract][Full Text] [Related]
20. Relationship between c-src tyrosine kinase activity and the control of glucose transporter gene expression.
Matsouka PT; Flier JS
Mol Endocrinol; 1989 Nov; 3(11):1845-51. PubMed ID: 2481817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
